KBC Group’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
ICM
KBC Group's CNMD Position: Q2 2026 in Review
KBC Group held its CONMED (CNMD) position steady in Q2 2026 at 899 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #1824.
KBC Group first reported a position in CNMD in Q2 2019 and has held it in 29 quarters since. The position peaked at $2.12M in Q4 2019. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.
- KBC Group held 899 shares of CONMED worth $29K as of Q2 2026.
- KBC Group left its CONMED share count unchanged in Q2 2026.
- CONMED made up ﹤0.01% of KBC Group's portfolio in Q2 2026, its #1824 holding.
- KBC Group first reported a position in CONMED in Q2 2019 and has held it in 29 quarters since.
- KBC Group's CONMED position peaked at $2.12M in Q4 2019.
- 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.
Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.